Identification of Active Compounds and Mechanism of Huangtu Decoction for the Treatment of Ulcerative Colitis by Network Pharmacology Combined with Experimental Verification
Wenwen Chen,Lin He,Lian Zhong,Jiayi Sun,Lilin Zhang,Daneng Wei,Chunjie Wu
DOI: https://doi.org/10.2147/DDDT.S328333
2021-09-29
Abstract:Wenwen Chen, 1, 2, &ast Lin He, 1, &ast Lian Zhong, 1 Jiayi Sun, 3 Lilin Zhang, 1 Daneng Wei, 1 Chunjie Wu 1 1 School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, People's Republic of China; 2 Department of Pharmacy, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610091, People's Republic of China; 3 Innovative Institute of Chinese Medicine and Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, People's Republic of China &astThese authors contributed equally to this work Correspondence: Daneng Wei; Chunjie Wu Email ; Introduction: Huangtu decoction (HTD) has been widely used in the treatment of gastrointestinal bleeding, ulcerative colitis (UC) and gastrointestinal tumors in China, but its active compounds and mechanism are still not clear yet. The present research aimed to identify the active compounds and mechanism of HTD for the treatment of UC. Methods: Firstly, the chemical compounds of HTD were qualitatively identified based on Q Exactive Orbitrap LC-MS/MS, and their potential targets were predicted through SwissTargetPrediction. Secondly, the differential expressed genes (DEGs) in colon tissues of UC patients and normal controls were retrieved from the GEO database. Thirdly, the overlapping targets of DEGs and the predicted targets were obtained and subjected to GO and KEGG analysis. Finally, the key targets in the most significantly enriched pathway were verified by in vivo experiment, and the protein and mRNA expressions of matrix metalloproteinase-1 (MMP1), MMP3, MMP7, MMP9 and MMP12 were determined by immunohistochemistry (IHC), Western blotting (WB) and quantitative real-time-PCR (qRT-PCR). Results: A total of 47 compounds were identified and 29 overlapping targets were obtained from HTD extract. The most significantly enriched pathway of overlapping targets involved was MMP. HTD improved the pathological damage in colon tissues of DSS-induced UC model and significantly decreased the serum levels of IL-1β and IL-6. The protein and mRNA expressions of MMP1, MMP3 and MMP9 in colon tissues were significantly decreased after HTD treatment. Conclusion: HTD treatment can alleviate the colonic inflammation via inhibiting MMPs including MMP1, MMP3 and MMP9. Keywords: bioinformatic analysis, ulcerative colitis, Huangtu decoction, matrix metalloproteinases Ulcerative colitis (UC) is a kind of chronic colitis involving colorectal mucosa and submucosa, which is mainly caused by chronic inflammation and ulceration. The incidence of UC is increasing worldwide, 1,2 and its clinical manifestations are primarily diarrhea, mucous purulent and bloody stool with abdominal pain and acute severe symptoms. It is estimated that the total annual economic burden of UC ranges from 14.9 billion in the United States and from €12.5 to €29.1 billion in Europe. 3 The duration and extensive feature of disease are considered as important factors associated with an increased risk of colorectal cancer in patients with UC. 4–6 Intense efforts have been made to elucidate the pathogeny of UC, but its molecular mechanisms are still poorly understood. Drug treatment is the first choice for UC, and the available drugs include mesalazine, corticosteroids, immunosuppressive drugs, and monoclonal antibodies to TNF-α currently in Western world. 6 Nevertheless, the limitations of these drugs are also obvious, such as poor therapeutic effects, high price and bothersome side effects. 7 In recent years, Traditional Chinese Medicine (TCM) has been gradually recognized as an effective method for treating various diseases not only in China and Southeast Asia, but also in many Western countries. 8,9 TCM also plays an important role in drug development, providing abundant novel compound lead sources. Huangtu Decoction (HTD) was first recorded in the Treatise on "JingGuiYaoLue (Synopsis of Golden Chamber)" written around 205 A.D by Zhang Zhongjing, a famous medical scientist in the Eastern Han Dynasty. Its prescription is composed of 7 medicinal herbs, including Terra Flava Usta, Rehmanniae Radix, Scutellariae Radix, Aconiti Lateralis Radix Praeparata, Asini Corii Colla, Atractylodis Macrocephalae Rhizoma and Glycyrrhizae Radix et Rhizoma . HTD has been mainly used in the treatment of bleeding symptoms, such as blood under stool, hematemesis, bleeding, metrorrhagia and dull blood color, and highly respected by doctors for thousands of years in China. 10,11 In modern time -Abstract Truncated-